SEC Form 4 · accession 0001567619-19-005679
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 7:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2019 | F | 481 | $61.01 | D | 28,772 | D | |
| Common StockF2 | Feb 26, 2019 | A | 5,081 | $0.00 | A | 33,853 | D | |
| Common StockF3 | Feb 26, 2019 | A | 5,081 | $0.00 | A | 38,934 | D | |
| Common StockF1 | Feb 27, 2019 | F | 409 | $57.98 | D | 38,525 | D | |
| Common StockF1 | Feb 28, 2019 | F | 812 | $58.71 | D | 37,713 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $61.01 | Feb 26, 2019 | A | 20,321 | A | — | Feb 25, 2026 | Common Stock | 20,321 | 20,321 | D |
Explanation of responses
- F1Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
- F2These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- F3Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period.
- F4Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.